The COPD Foundation, a 501(c)(3) nonprofit organization, has a mission to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. We do this by expanding services, accelerating innovations for more effective and affordable treatments, and promoting awareness and education, with the overarching goal of preventing chronic lung disease, slowing its progression, and ultimately finding a cure.
Chiesi USA
Chiesi is a global biopharmaceutical company that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialty care. Through its US affiliate headquartered in Cary, NC, the company is bringing a fresh perspective to the US respiratory landscape that is informed by 90 years of global pharmaceutical leadership. As a privately-owned, values-driven pharmaceutical company that is committed to generating economic value in a way that benefits society, Chiesi seeks to create lasting, shared value for people, patients, the planet, and our business.
Canadian Thoracic Society
The Canadian Thoracic Society (CTS) is Canada’s national inter-professional specialty society for respirology bringing together over 1,000 members representing specialists, physicians, researchers and healthcare professionals from a variety of disciplines working in respiratory health. For more information on CTS, please visit our website at www.cts-sct.ca
Broncus Medical, Inc.
Broncus Medical, the leader in virtual bronchoscopic navigation, has developed Archimedes™ total lung access platform, including BTPNA – Bronchoscopic Trans-Parenchymal Nodule Access. The Archimedes® Navigation System integrates CT and fused fluoroscopy to provide 3D, real-time Guided Transbronchial Needle Aspiration (TBNA) and Bronchoscopic Trans-Parenchymal Nodule Access (BTPNA). The system combines nodule, vessel and airway mapping technology to ensure a safe and efficient Guided TBNA or BTPNA procedure. Archimedes is the only navigation system that provides multiple bronchoscopic techniques to access a nodule regardless of size, location or the presence of a bronchus sign. Broncus Medical is proud to introduce next generation pulmonary technology from access, diagnose to treatment.
Boehringer Ingelheim Pharmaceuticals
We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches. We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations. Read more here: https://www.boehringer-ingelheim.com/human-health/cancer | Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.us | At Boehringer Ingelheim we are driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our FOCUS articulates who we are and what we strive for, why we exist, how we work and what we want to achieve.
Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. To deliver on our mission to transform patient care and improve outcomes through personalized diagnostics, we provide advanced diagnostic tests and custom diagnostic development services. | Biodesix is a leading diagnostic solutions and services company with a focus in lung disease. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood-based Nodify Lung® Nodule Risk Assessment testing portfolio evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ portfolio supports treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting the time to treatment. For more information, www.biodesix.com.
Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. Baxter employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Hillrom products are now part of Baxter’s global portfolio. | Baxter International Inc. through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. | Baxter products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes. For 90 years, we have been at the critical intersection of saving and sustaining lives. We have pioneered significant medical innovations that changed healthcare. From the first commercially produced intravenous solutions to today’s leading acute, nutritional, renal and surgical care innovations, we are committed to providing leading healthcare solutions.